Bristol-Myers Squibb GmbH & Co. KGaA
Paris, France (ots/PRNewswire) - Yervoy, an innovative immuno-oncology therapy that has demonstrated durable long-term survival in some patients,[1],[2] is now approved for use in previously-untreated patients Bristol-Myers Squibb today announced that the European Commission (EC) has approved YERVOY(R) (ipilimumab) ...
Paris (ots/PRNewswire) - LABEL 5 is adding a new expression in its brand family: LABEL 5 18 yo Extra Rare. Unveiled at TFWA Cannes next October, LABEL 5 Extra Rare respects the traditional Scotch Whisky codes whilst moving away the presentation to a contemporary blue style. To view the Multimedia News Release, please click: http://www.multivu.com/mnr/63476-launch-of-label-5-18-YO-extra-rare LABEL 5 Extra Rare meets the ...
Paris (ots/PRNewswire) - G.H.MUMM House of Champagne unveiled its latest creation - The G.H.MUMM Sabre by Ross Lovegrove - an exceptional contemporary interpretation of one of the great rituals of Champagne by internationally acclaimed Designer Ross Lovegrove. To view the Multimedia News Release, please click: ...
Paris (ots/PRNewswire) - Sanofi announced today at the 49th Annual Meeting of the European Association for the Study of Diabetes (EASD), Barcelona, the CE Mark of JuniorSTAR(R), a new halfunit insulin reusable pen that can be used with Lantus(R) (insulin glargine), Apidra(R) (insulin glulisine) or Insuman(R) ...
Paris (ots) - - CE marks obtained for MyStar Extra® and MyStar SylkFeel® lancing device, respectively, enabling commercialization in the European Union - Scientific data presented at EASD 2013 demonstrate robustness and accuracy[i],[ii] of estimated A1c algorithm in MyStar Extra® At the annual meeting of the ...
Paris (ots/PRNewswire) - - Findings Consistent with Known Post-Prandial Effect of Lyxumia Supporting Combination with Basal Insulin - Sanofi announced today new GetGoal-L sub-analysis results showing that reductions in HbA1c with Lyxumia(R) (lixisenatide), when added to basal insulin, were greatest in patients with ...
Paris (ots/PRNewswire) - - American graduate student took delivery of the 100,000th electric vehicle - Renault-Nissan EVs outsell all other major automakers combined - Nissan LEAF remains world's best-selling EV - With its latest EV ZOE, Renault expands its zero-emission lineup and reinforces its leadership in Europe The Renault-Nissan Alliance has sold its 100,000th zero-emission car. To view the Multimedia News Release, ...
Paris (ots/PRNewswire) - - First once-daily prandial GLP-1 receptor agonist offering a new treatment option for Japanese people living with type 2 diabetes - Sanofi announced today that Japan's Ministry of Health, Labour and Welfare (MHLW) has approved the manufacturing and distribution of Lyxumia(R) (lixisenatide) ...
Paris (ots/PRNewswire) - - Synergies up 54% from 1.75 billion euros in previous year - Sharp increase shows partnership's momentum keeps accelerating - Purchasing, powertrain and vehicle engineering areas remain the biggest contributors - Synergies expected to keep growing with acceleration in non-engineering areas ...
Paris (ots/PRNewswire) - - EDITION I demonstrated similar blood sugar control with fewer night-time low blood sugar events compared to Lantus(R)- - Topline results of EDITION II consistent with EDITION I findings - Sanofi announced today that the first phase 3 study results (EDITION I) for its investigational new insulin U300 showed equivalent blood sugar control with ...
Paris (ots/PRNewswire) - Sanofi announced today that clinical data highlighting the company's ongoing commitment to advancing diabetes care will be presented at the American Diabetes Association (ADA) 73rd Scientific Sessions in Chicago, USA (June 21-25, 2013). In total, more than 60 abstracts representing new data ...
Bristol-Myers Squibb GmbH & Co. KGaA
Paris (ots/PRNewswire) - AMPLE Study results highlighted during a press conference at the European League Against Rheumatism (EULAR) Annual congress - Year 2 data shows similar efficacy between ORENCIA plus methotrexate (MTX) and Humira plus MTX, consistent with the year 1 result which demonstrated comparable ...
Democratic Republic of the Congo
Paris (ots/PRNewswire) - Following the initialling of an energy cooperation treaty between the Democratic Republic of the Congo and the Republic of South Africa on 7 March 2013, the DRC has now re-launched the process for the selection of a developer and established the objective of laying the first foundation stone ...
Paris (ots/PRNewswire) - Altuglas International, a subsidiary of the Arkema Group is a partner of the film Mood Indigo coming to theather today. This is the film adaptation of the eponymous book of the french author Boris Vian published in 1947. To view the Multimedia News Release, please click: http://www.multivu.com/mnr/60651-altuglas-partner-film-mood-indigo-michel-gondry Michel Gondry, the famous Director has swarmed ...
Geneva, Switzerland/Paris, France (ots) - Following on the partnership announced last year WISeKey and Qwant have launched a Joint Venture with the name WISeQwant.com associating WISekey's digital identity management, mobile apps and encryption with Qwant Search technologies. WISeQwant defines a new paradigm for ...
Paris (ots/PRNewswire) - - Worldwide invitation to create and submit concepts for a potential next-generation insulin delivery device - Sanofi announced today that it is accepting submissions for Ignite: The Diabetes Ideas Challenge ("Ignite Challenge"). The web-based Ignite Challenge invites patients, caregivers, designers, engineers, and innovators from around the ...
OneAccess and Eutelsat Communications
Paris (ots/PRNewswire) - New generation of performance-enhanced satellite-based VPN services immediately available across entire KA-SAT coverage in Europe, the Middle East and North Africa Eutelsat Communications and OneAccess, the leading manufacturer of multi-service routers and Carrier Ethernet access devices, ...
Paris (ots/PRNewswire) - On 26 February 2013, Etam will open Fashion Week with its "Girls Only!" Live Show at the Bourse de Commerce (Paris 1st arrondissement). "GIRLS ONLY!" For this sixth edition, the Etam Lingerie and Natalia Vodianova for Etam collections will once again create a buzz to the sounds of the new international women's musical scene, under the artistic direction of Mark Ronson. To view the Multimedia News Release, please click: ...
Paris, France (ots) - - Data presented at ATTD by Sanofi will focus on the company's integrated portfolio of therapeutic solutions, blood glucose monitoring, insulin delivery and contributions to advancing diabetes research - Sanofi (EURONEXT : SAN and NYSE : SNY) announced today that its comprehensive portfolio of ...
Paris (ots/PRNewswire) - - Despite recession in Europe and slowing pace of sales in China, global sales were a record 8.1 million units - Strongest growth came from emerging markets and the United States - Zero-emission sales up more than 80% from 2011 The Renault-Nissan Alliance sold a record 8,101,310 vehicles in 2012, representing one in 10 new cars sold worldwide. ...
Paris (ots/PRNewswire) - - Sanofi portfolio expands to offer first once-a-day prandial GLP-1 receptor agonist - Sanofi announced today that the European Commission has granted Marketing Authorisation in Europe for Lyxumia(R) (lixisenatide). Lyxumia(R), the first once-daily prandial GLP-1 receptor agonist, is ...
Bristol-Myers Squibb GmbH & Co. KGaA
Paris (ots/PRNewswire) - My CML Life Online Resource Centre Empowers and Guides Patients with CML Through Different Stages of Their Journey Bristol-Myers Squibb Company today announced the introduction of "My CML Life", a disease awareness website for patients with chronic myeloid leukaemia (CML). In recognition of ...
Bristol-Myers Squibb GmbH & Co. KGaA
Paris (ots/PRNewswire) - Proven biologic is first therapy available in both subcutaneous and intravenous formulations for adults with moderate to severe active rheumatoid arthritis Bristol-Myers Squibb announced today that the European Commission has granted marketing authorisation for the subcutaneous formulation of ORENCIA(R) (abatacept), in combination with ...
Paris (ots/PRNewswire) - NTT Communications, a member of the NTT Group and the number one Fortune Global 500 telecommunications group, has been a loyal supplier since 1998 to Agence France-Presse (AFP), a global news agency delivering fast, worldwide news. Through its ability to deliver a quality and responsive service, NTT Communications has consistently been able to meet the demands of AFP's increased flow of ...
Paris (ots/PRNewswire) - Boston Scientific Corporation has received CE Mark approval for use of its PRECISION(TM) PLUS SPINAL CORD STIMULATOR (SCS) System in patients with the system and are in need for magnetic resonance imaging (MRI) head-only scans. The PRECISION PLUS SCS System is the world's first rechargeable SCS device. This approval provides physicians with an ...
Paris (ots/PRNewswire) - Boston Scientific Corporation has received CE Mark approval for use of its PRECISION(TM) PLUS SPINAL CORD STIMULATOR (SCS) System, the world's first rechargeable SCS device, in peripheral nerve stimulation for patients with chronic intractable pain of the trunk. Peripheral nerve stimulation ...
Paris (ots/PRNewswire) - The Renault-Nissan Alliance will provide 15,000 vehicles in an exclusive fleet contract with the Paris-based nutritional food company Danone. The first-of-its-kind deal for the Alliance provides a full range of vehicles to Danone in 25 countries for at least five years. Danone, one of the fastest growing food companies in the world, selected ...
Bristol -Myers Squibb Company and Otsuka Pharmaceutical Co. Ltd
Paris (ots/PRNewswire) - Results Presented at 17th Congress of the European Hematology Association Bristol-Myers Squibb Company and Otsuka Pharmaceutical Europe Ltd., today announced results from the 3-year follow-up of the DASISION trial, which show that first-line treatment with SPRYCEL(R) 100 mg results infaster ...
Bristol-Myers Squibb & Otsuka Pharmaceutical Europe Ltd.
Paris (ots/PRNewswire) - Results Presented at 17th Congress of the European Hematology Association Bristol-Myers Squibb Company and Otsuka Pharmaceutical Europe Ltd., today announced six-year follow-up results from a Phase 3 randomised, open-label, dose-optimisation study of SPRYCEL(R) (dasatinib) in Philadelphia ...